SEC Form 4 · accession 0001179110-18-004608
Blueprint Medicines Corp · BPMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marion Dorsch
Officer — Chief Scientific Officer
Period of report
Mar 15, 2018
Accepted (ET)
Mar 19, 2018 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597264
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 15, 2018 | M | 2,300 | $37.11 | A | 2,300 | D | |
| Common Stock | Mar 15, 2018 | S | 2,300 | $100.07 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $37.11 | Mar 15, 2018 | M | 2,300 | D | — | Nov 21, 2026 | Common Stock | 2,300 | 119,200 | D |
Explanation of responses
- F1Effected pursuant to a trading plan adopted on December 18, 2017 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F2This option was granted on November 21, 2016. This option vested with respect to 25% of the shares underlying the option on November 21, 2017 and vests as to an additional 1/48th of the shares underlying the option each month thereafter.